Study directory

Anxiety studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4175studies shown
Showing 1,633-1,644 of 4,175
Drug study icon
CompletedEUCTR 2010-020906-14

Randomized controlled trial of escitalopram versus placebo for patients with irritable bowel syndrome and panic disorder.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrugA study involving a medication or substance.
Countries
Netherlands
Sponsor
MUMC
Condition
Anxiety
Drug study icon
CompletedEUCTR 2007-000051-34

Randomized, open-label, controlled and multicenter trial on a new pattern of Paroxetine up-titration for Panic Disorder. Comparison between two different dose regimens.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrug
Countries
Italy
Sponsor
ITALFARMACO
Condition
Anxiety
Drug study icon
TerminatedEUCTR 2012-003191-39

The effect of a single-dose of d-cycloserine on the basic effects of cognitive-behaviour therapy for panic disorder - a randomized placebo-controlled trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrug
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Anxiety
Drug study icon
Recruitment unclearEUCTR 2014-004937-15

A randomized, double-blinded, placebo and lorazepam-controlled, four-way crossover, Phase II study to evaluate the effects of single oral administration of BNC210 on brain activity changes captured...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrug
Countries
United Kingdom
Sponsor
BIONOMICS LIMITED
Condition
Anxiety
Other study type icon
Not recruitingISRCTN55236453

Evaluation of CBT in older persons with anxiety: a study

This study is looking at whether a digital support tool can help people with Mental and Behavioural Disorders: anxiety, Mental and Behavioural Disorders, or anxiety. Participants take part in a digital support tool and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Anxiety.

AnxietyOther
Countries
United Kingdom
Sponsor
Department of Health
Condition
Anxiety
Other study type icon
Not recruitingISRCTN15721784

Evaluation of relaxation techniques to reduce anxiety in patients undergoing MRI investigations

This observational study is following people with anxiety or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United Kingdom
Why is this study shown?

This study is directly about Anxiety.

AnxietyOther
Countries
United Kingdom
Sponsor
Department of Health
Condition
Anxiety
Other study type icon
WithdrawnNCT04211376

A Non-Interventional Study to Explore the Role of Gut Flora in Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In Ventura
Why is this study shown?

This study is directly about Anxiety.

Anxiety, DepressionObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
ProgenaBiome
Condition
Anxiety, Depression
Drug study icon
CompletedNCT03491384

Anxiety, Inflammation, Stress, and Cannabinoids

This summary needs review. Please check the official study record and contact the research team for details.

In Boulder
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrugFrom 21 Years to 70 Years
Countries
United States
Sponsor
University of Colorado, Boulder
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.